Best 360 lipo and breast augmentation package Turkey

Building the combined surgical map before travel

At Plastic Surgery Turkey, a combined package starts with separate clinical decisions rather than a promise to fit every procedure into one stay. The abdominal and flank contour is reviewed separately from breast tissue, implant or fat-transfer options and skin quality.

The medical history, current medicines, previous operations and travel timing are reviewed for every part of the plan. An online discussion can prepare the visit, but examination and safety checks determine whether the requested combination is appropriate.

Choosing a sequence that protects safety

The teams consider operative time, fluid management and whether contouring and breast surgery should share a session. A single anaesthetic session is considered only when the treating teams judge its length and risk profile suitable; staging remains a valid clinical option.

Flight dates should follow the treatment itinerary, not set it. Ask for assessment appointments, procedure days, first reviews and contingency time to be shown separately before booking travel.

Making recovery practical for overlapping procedures

Compression needs for 360 lipo and protection of the breast area must be planned together without assuming identical timelines. When instructions differ, the more cautious restriction should guide activity, sleeping positions, wound care and return travel.

Arrange support for the first days, avoid adding tours or cosmetic appointments, and seek local medical advice promptly if symptoms worsen rather than settle. Keep the discharge information available for any clinician who later sees you.

Reading a multi-procedure quote line by line

Ask for the treated contour zones, breast technique, garments, hospital care and any optional body-contouring additions to be itemised.

A written offer should identify each procedure, anaesthesia where applicable, tests, hospital care, hotel nights, transfers, medication, planned reviews and optional extras. It should also state the next step if one element is deferred after assessment.

Questions from you

These questions help you ask a hospital or clinic for a clear written treatment plan. They do not promise a particular method, device, follow-up arrangement or payment responsibility. Plastic Surgery Turkey is an independent information, marketing and enquiry platform, not a healthcare provider or medical-tourism intermediary. With your consent, an enquiry may be shared with an authorised healthcare partner.

What is each part of the plan intended to correct: fat, loose skin, muscle separation or contour?

A written plan should name the problem being treated rather than rely on a body-contouring label. Liposuction removes fat but does not reliably correct loose skin. Heat-based tightening such as J-Plasma/Renuvion has its own heat-injury risks and is not a substitute for the skin removal of tummy tuck, arm lift or thigh lift. A hanging abdominal apron still requires separate discussion, as does rectus-muscle separation. Source: ASPS liposuction safety.

How will fluid balance, blood loss and operative time be kept within a safe plan?

Ask how planned suction volume, fluid replacement, lidocaine dose, anaesthetic time and your own risk factors are being managed. More than five litres is commonly treated as a trigger for additional planning and monitoring, not as a universal safe ceiling or a target. The written plan should explain when the scope would be reduced or staged instead of treating several requested areas as automatically suitable. Source: ASPS liposuction safety.

How are seroma, wound opening and skin loss recognised and treated?

ASPS includes fluid collections, impaired wound healing and heat injury among liposuction risks. A seroma can feel like a wave beneath an incision: a small collection may be reabsorbed, while one that persists may need aspiration; if infection develops or the collection threatens the skin, drainage may be needed. A separating wound or blackening skin can signal tension, smoking, infection or impaired circulation and should not be treated by closing it at home under a dressing. The plan should state the use of drains, compression and review date. Fever, unpleasant smell, a wound opening or rapidly increasing swelling should be reported without delay. Source: ASPS liposuction safety.

After I return home, who follows a wound problem or suspected clot, and who pays for extra treatment?

Before overseas cosmetic surgery, the NHS recommends agreeing where reviews happen and what further surgery and return travel could cost; travel insurance commonly excludes surgical complications. It uses 5–7 days after liposuction or breast surgery and 7–10 days after tummy tuck as travel-planning windows, while individual clearance belongs to the surgeon. A painful swollen calf needs urgent assessment. Sudden breathlessness or chest pain is an emergency, even without calf symptoms. This page does not say that any partner pays for those items. Source: NHS advice on cosmetic surgery abroad.

What implant will be used, and will I receive an implant card?

For legally marketed breast implants, the FDA expects labelling that identifies device materials and a patient device card that can identify the implant after surgery. Products may contain saline or silicone gel and differ in shape, style and surface, including smooth or textured options. The written surgical plan should choose volume and profile using breast-base width, tissue cover and the projection discussed with the patient; this page does not recommend a brand. For approved saline implants, the FDA does not recommend an umbilical incision because of rupture risk. Sources: FDA points to consider before breast implants, FDA breast implant risks.

What long-term imaging plan applies to silicone implants, alongside routine breast screening?

Breast implants are not lifetime devices, and later removal or replacement may be needed. Saline deflation is often visible; a silicone rupture can be silent and may not be found by examination alone. The FDA describes MRI as the most effective method for detecting silent silicone rupture and accepts ultrasound as a screening alternative for people without symptoms. Its labelling guidance suggests the first ultrasound or MRI at 5–6 years and then every 2–3 years for asymptomatic silicone-gel implant patients; symptoms or an unclear ultrasound may call for MRI. This surveillance is separate from mammography for breast-cancer screening, and later costs should be discussed separately. Sources: FDA breast implant risks, FDA breast implant labeling guidance, and American Society of Plastic Surgeons implant-safety guidance.

How would capsular contracture, rupture, displacement or a rare implant-associated disease be recognised?

Capsular contracture is tightening of the scar capsule around an implant. FDA Baker grades run from I, soft and natural, to II, firmer but natural, III, firm and distorted, and IV, firm, painful and distorted; grades III and IV often need another operation and can recur after correction. Displacement can occur at surgery or later, with gravity, trauma or the capsule contributing. Saline rupture usually causes loss of size or shape. Silicone rupture may present with smaller size, shape change, firm lump, asymmetry, pain, numbness or swelling, or no symptom. BIA-ALCL is not breast cancer: persistent swelling, pain or another change needs examination, imaging and sometimes fluid or tissue tests. Confirmed disease usually requires implant and capsule removal, sometimes with chemotherapy or radiotherapy. FDA separately tracks SCC and other lymphomas in the capsule. Fatigue, brain fog and joint pain are sometimes called breast implant illness, but its cause is unclear and removal cannot promise resolution. Source: FDA breast implant risks.

Which incision is planned for my anatomy, and how much asymmetry can remain?

The FDA defines asymmetry as a difference in breast size, shape or level, and a difference already present may not disappear completely. For augmentation, the written plan should identify the incision, implant pocket and expected scar location. FDA does not recommend a navel incision for approved saline implants because of rupture and deflation. In an exchange, the new incision commonly uses the old scar, whose position, thin tissue and capsule can limit the choice. Scars are permanent and may widen; a future scar revision should not be assumed to be included in the first fee. Source: FDA breast implant risks.

If an implant or wound problem appears after I return home, who follows it and which costs are whose?

The NHS notes that an overseas clinic may not have the same follow-up duty as a UK surgeon and a doctor may not be arranged in the patient’s own country. Before surgery, put the complication route, review location, return-travel cost and possible further-surgery cost in writing; travel insurance usually excludes surgical complications, and provider insurance is a separate question. FDA notes removal or replacement may not be insured even after a complication. A device card or warranty does not pay the surgeon’s fee, wound care, admission or revision. Ask for the scope to be separated in writing. Increasing swelling or bruising, fever, wound opening, visible implant material, or a new one-sided lump or fluid should be reported without delay. This page promises no partner payment. Sources: NHS advice on cosmetic surgery abroad, FDA points to consider before breast implants.